Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress
Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress
Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran
Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement
The combined diabetes medicine was produced by Iranian scientists!
Actoverco launches diabetes drug “Trytis”
Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress
Presentation of Actoverco’s Diverse Product Portfolio at the 23rd Annual Conference of the Iranian Dermatologists Association
Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress
Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association
